Frazier Healthcare Partners — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Sidewinder Therapeuticssidewinderbio.cominSeries B · Apr 2026 · $140M
Sidewinder Therapeutics is a biotechnology company focused on oncology drug discovery and development, working on next-generation cancer treatments.
BiotechHealthtechMedical DevicesSan Diego, US
Eric Murphy(Chief Executive Officer, Co-Founder, & Director)in
Co-investorsAstellas Venture Management LLCDCVC (Data Collective)DCVC BioFrazier Life SciencesLongwood FundNovartis Venture Fund+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.